GNA12, G protein subunit alpha 12, 2768

N. diseases: 130; N. variants: 16
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0025202
Disease: melanoma
melanoma
0.040 Biomarker disease BEFREE The 31-GEP test identifies high-risk patients who are likely to experience recurrence or die of melanoma within low-risk groups of subpopulations of patients with CM who have SLN-negative disease, stage I to IIA tumors, and thin tumors. 30081113 2019
CUI: C0025202
Disease: melanoma
melanoma
0.040 Biomarker disease BEFREE Conversely, in one case with a "benign" 23-GEP result, aCGH testing supported assessment as melanoma. 29752733 2018
CUI: C0025202
Disease: melanoma
melanoma
0.040 GeneticVariation disease BEFREE Ulceration appears to be the most important factor impacting clinicians when deciding to order the 31-GEP test to assess risk for melanoma metastasis.J Drugs Dermatol.2018;17(5):544-547. 29742186 2018
CUI: C0025202
Disease: melanoma
melanoma
0.040 Biomarker disease BEFREE Objective: To determine the impact of 31-GEP test results on management decisions made by dermatology PA/NPs for cutaneous melanoma patients. 30500144 2018